Revelation Biosciences, Inc. (REVB)

Revelation Biosciences Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for REVB.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for REVB.

Recommendation Trends

Rating	Dec '22	Jan '23	Feb '23
Strong Buy	1	1	0
Buy	0	0	0
Hold	0	0	0
Sell	0	0	0
Strong Sell	0	0	0
Total	1	1	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jonathan Aschoff Roth MKM	Roth MKM	Strong Buy Maintains $150 → $450	Strong Buy	Maintains	$150 → $450	+21,431.10%	Feb 14, 2023
Jonathan Aschoff Roth Capital	Roth Capital	Strong Buy Initiates $12,600	Strong Buy	Initiates	$12,600	+602,770.81%	Feb 17, 2022

More Analyst Ratings

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  n/a
• EPS This Year:
  -20.71

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	-	-	-	-	-	-	-	-	2.33M	44.11M
Revenue Growth	-	-	-	-	-	-	-	-	-	1,793.13%
EPS	-	-714.00	-1,275.00	-149.20	-0.53	-20.71	-19.25	-3.42	-2.40	1.85
EPS Growth	-	-	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	n/a	n/a	n/a	2.4M	45.4M
Avg	n/a	n/a	n/a	2.3M	44.1M
Low	n/a	n/a	n/a	2.2M	42.4M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	-	-	-	-	1,848.8%
Avg	-	-	-	-	1,793.1%
Low	-	-	-	-	1,718.9%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	-5.16	-3.41	-3.52	-2.47	1.90
Avg	-20.71	-19.25	-3.42	-2.40	1.85
Low	-34.99	-33.81	-3.28	-2.30	1.77

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	-	-	-	-	-
Avg	-	-	-	-	-
Low	-	-	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.